Julien Paganin-Robert

Paris, 75005, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Antimalarial cytoskeletal targeting with broad apicomplexan activity.

Antimalarial cytoskeletal targeting with broad apicomplexan activity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 24, 2026

Dynamics of the β-cardiac myosin auto-inhibited state explain cardiomyopathy pathogenesis.

Dynamics of the β-cardiac myosin auto-inhibited state explain cardiomyopathy pathogenesis.

Journal: Nature communications

Published: January 16, 2026

Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy.

Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy.

Journal: The EMBO journal

Published: April 23, 2024

Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite antagonistic effects in heart contraction.

Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite antagonistic effects in heart contraction.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2023

Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction.

Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction.

Journal: Nature communications

Published: October 30, 2023

Cryo-EM structure of the folded-back state of human β-cardiac myosin.

Cryo-EM structure of the folded-back state of human β-cardiac myosin.

Journal: bioRxiv : the preprint server for biology

Published: May 03, 2023

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy.

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy.

Journal: Nature cardiovascular research

Published: September 12, 2022

Cryo-EM structure of the folded-back state of human β-cardiac myosin.

Cryo-EM structure of the folded-back state of human β-cardiac myosin.

Journal: Nature communications

Published: August 02, 2022

Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design.

Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design.

Journal: Nature communications

Published: July 31, 2022

A Perspective for Ménière's Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2.

A Perspective for Ménière's Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2.

Journal: Biomolecules

Published: March 03, 2022

The actomyosin interface contains an evolutionary conserved core and an ancillary interface involved in specificity.

The actomyosin interface contains an evolutionary conserved core and an ancillary interface involved in specificity.

Journal: Nature communications

Published: November 10, 2020

Voltage-gating of aquaporins, a putative conserved safety mechanism during ionic stresses.

Voltage-gating of aquaporins, a putative conserved safety mechanism during ionic stresses.

Journal: FEBS letters

Published: September 16, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026